The I1-imidazoline receptor and its cellular signaling pathways

Annals of the New York Academy of Sciences

Volumn 881, Issue , 1999, Pages 35-53

  Ernsberger, Paul ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 1H 3 BENZAZEPINE; ADENYLATE CYCLASE; ARACHIDONIC ACID; CALCIUM; CHOLINE; DIACYLGLYCEROL; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANYLATE CYCLASE; ICOSANOID; IMIDAZOLINE I1 RECEPTOR; PHENOXYBENZAMINE; PHOSPHATIDYLINOSITIDE; SODIUM ION; CATECHOLAMINE; DRUG RECEPTOR; IMIDAZOLE DERIVATIVE; IMIDAZOLINE RECEPTORS; PHOSPHOLIPID;

BINDING AFFINITY; BINDING SITE; CALCIUM TRANSPORT; CELLULAR DISTRIBUTION; CONFERENCE PAPER; ENZYME ACTIVATION; ENZYME INHIBITION; GENE INDUCTION; HUMAN; HYDROLYSIS; NONHUMAN; PROTON SODIUM EXCHANGE; RECEPTOR BINDING; RECEPTOR OCCUPANCY; SIGNAL TRANSDUCTION; ANIMAL; CELL MEMBRANE; CHEMISTRY; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; BINDING SITES; CALCIUM; CATECHOLAMINES; CELL MEMBRANE; GTP-BINDING PROTEINS; HUMANS; IMIDAZOLES; PHOSPHOLIPIDS; RECEPTORS, DRUG; SIGNAL TRANSDUCTION;

EID: 0032588742     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09339.x     Document Type: Conference Paper

References (86)

1. Bousquet, P., J. Feldman, R. Bloch & J. Schwartz. 1984. Central cardiovascular effects of α-adrenergic drugs: Differences between catecholamines and imidazolines. J. Pharmacol. Exp. Ther. 230: 232-236.
2. 2-adrenoceptors in the ventrolateral medulla. Eur. J. Pharmacol. 134: 1-13.
3. Bricca, G., M. Dontenwill, A. Molines, J. Feldman, A. Belcourt & P. Bousquet. 1989. The imidazoline preferring receptor: Binding studies in bovine, rat and human brainstem. Eur. J. Pharmacol. 162: 1-9.
4. Ernsberger, P., R. Giuliano, R. N. Willette & D. J. Reis. 1990. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J. Pharmacol. Exp. Ther. 253: 408-418.
5. 2-adrenoceptors and imidazoline binding sites: Distribution of imidazoline binding sites in rat brain. Brain Res. 514: 15-21.
6. 1-Imidazoline receptors: Definition, characterization, distribution and transmembrane signalling. Ann. N.Y. Acad. Sci. 763: 22-42.
7. 2-adrenergic receptors in the carotid body response to isocapnic hypoxia. Respir. Physiol. 83: 353-364.
8. 2-imidazoline binding sites on monoamine oxidases. J. Biol. Chem. 270: 9856-9861.
9. Roesiek, W. R.. 1984. Agonist radioligands for identifying functional neurotransmitter receptors: Introduction. Fed. Proc. 43: 2765-2766.
10. 1 receptors in the ventrolateral medulla and their role in cardiorespiratory control. In Ventral Brainstem Mechanisms and Control Functions. O. Trouth, R. Millis, H. Kiwell-Schone & M. Schläfke, Eds.: 319-358. Marcel Dekker. New York.
11. 2-adrenoceptor states plus a non-adrenergic site on human platelet plasma membranes. Biochem. Pharmacol. 42: 569-584.
12. 1-imidazoline sites. Ann. N.Y. Acad. Sci. 763: 163-168.
13. 1-imidazoline-binding site is a functional receptor mediating vasodepression via the ventral medulla. Am. J. Physiol. Regul. Integr. Comp. Physiol. 273: R1572-R1579.
14. Campbell, W. R. & D. E. Potter. 1995. Centrally mediated ocular hypotension: Potential role of imidazoline receptors. Ann. N.Y. Acad. Sci. 763: 463-485.
15. 1) receptors in modulating aqueous humor dynamics. J. Ocul. Pharmacol. 10: 393-402.
16. 1-imidazoline receptors inhibits reflexly induced tracheal smooth muscle contraction. Atemweg. Lungenkrank. 22: 370-373.
17. Smyth, D. D., F. K. Darkwa & S. B. Penner. 1995. Imidazoline receptors and sodium excretion in the rat kidney. Ann. N.Y. Acad. Sci. 763: 340-352.
18. Evinger, M. J., P. Ernsberger, S. Regunathan & D. J. Reis. 1995. Regulation of phenylethanolamine N-methyltransferase gene expression by imidazoline receptors in adrenal chromaffin cells. J. Neurochem. 65: 988-997.
19. 1-imidazoline receptors in PC12 cells and rostral ventrolateral medulla. Brain Res. 749: 335-339.
20. 1-imidazoline receptors to diacylglyceride accumulation in PC12 rat pheochromocytoma cells. Mol. Pharmacol. 49: 668-675.
21. 2-adrenoceptors are blocked. Naunyn-Schmiedeberg's Arch. Pharmacol. 340: 712-714.
22. 1-imidazoline agonist moxonidine. Ann. N.Y. Acad. Sci. 763: 401-404.
23. 2-Adrenergic, but not imidazole, agonists activate NaCl cotransport in rabbit tracheal epithelial cells. Am. J. Physiol. Cell Physiol. 264: C568-C576.
24. 1-imidazoline agonist. Cardiovasc. Drugs Ther. 8(Suppl. 1): 27-41.
25. 1-imidazoline receptors in the rostral ventrolateral medulla. J. Cardiovasc. Pharmacol. 24(Suppl. 1): S1-S8.
26. 1-imidazoline receptor activation on responses of hypoglossal and phrenic nerve to chemical stimulation. Ann. N.Y. Acad. Sci. 763: 445-462.
27. 1-imidazoline binding sites. Neurochem. Int. 30: 17-23.
28. Piletz, J. E. & K. Sletten. 1993. Nonadrenergic imidazoline binding sites on human platelets. J. Pharmacol. Exp. Ther. 267: 1493-1502.
29. Ernsberger, P., G. Feinland, M. P. Meeley & D. J. Reis. 1990. Characterization and visualization of clonidine-sensitive imidazole sites in rat kidney which recognize clonidine-displacing substance. Am. J. Hypertens. 30: 90-97.
30. 2-adrenergic binding sites in renal tubule epithelial cells. FASEB J. 7: A145.
31. 1-imidazoline receptors. J. Cardiovasc. Pharmacol. 20(Suppl. 4): S1-S10.
32. 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 273: 1162-1171.
33. 1-imidazoline sites. J. Pharmacol. Exp. Ther. 264: 172-182.
34. Weber, M. A., W. F. Graettinger & D. G. Cheung. 1990. Centrally acting sympathetic inhibitors. In Hypertension: Pathophysiology, Diagnosis, and Management. J. H. Laragh & B. M. Brenner, Eds.: 2251-2261. Raven Press. New York.
35. l-proteins in human erythroleukaemia (HEL) cells. No evidence for a functional role of imidazoline receptors in modulating calcium. Biochem. Pharmacol. 49: 187-196.
36. El Mas, M. M. & A. A. Abdel Rahman. 1995. Upregulation of imidazoline receptors in the medulla oblongata accounts for the enhanced hypotensive effect of clonidine in aortic barodenervated rats. Brain Res. 691: 195-204.
37. 2-adrenergic receptors by hypoxia. Soc. Neurosci. Abstr. 22: 1338.
38. 2-adrenergic receptors: Implications for depression. Crit. Rev. Neurobiol. 9: 29-66.
39. 1-imidazoline receptors in mood disorders. Ann. N.Y. Acad. Sci. 763: 510-519.
40. 1-imidazoline sites in rat renal medulla: Binding properties and up-regulation by subpressor angiotensin infusion. Hypertension 18: 380.
41. 2-adrenergic receptors by genetic hypertension and obesity and by weight cycling. FASEB J. 10: A691.
42. Hamilton, C. A., E. Jardine & J. L. Reid. 1993. Down-regulation of imidazoline sites in rabbit kidney. Eur. J. Pharmacol. 243: 95-97.
43. Li, G., S. Regunathan, C. J. Barrow, J. Eshraghi, R. Cooper & D. J. Reis. 1994. Agmatine: An endogenous clonidine-displacing substance in the brain. Science 263: 966-969.
44. Piletz, J. E., D. N. Chikkala & P. Ernsberger. 1995. Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. J. Pharmacol. Exp. Ther. 272: 581-587.
45. Wang, H., S. Regunathan, D. McGowan, S. Bramwell & D. J. Reis. 1997. An antiserum to idazoxan recognizes an immunoreactive substance in human serum and cerebral spinal fluid which is not agmatine. Neurochem. Int. 30: 85-94.
46. 3H]clonidine. Neurochem. Int. 25: 183-191.
47. 2-adrenergic receptor subtypes in a cell type-specific manner. J. Biol. Chem. 267: 24045-24052.
48. Regunathan, S., M. P. Meeley & D. J. Reis. 1990. Effect of clonidine on second messenger systems in rat adrenal gland. Life Sci. 47: 2127-2133.
49. Regunathan, S., M. J. Evinger, M. P. Meeley & D. J. Reis. 1991. Effects of clonidine and other imidazole-receptor binding agents on second messenger systems and calcium influx in bovine adrenal chromaffin cells. Biochem. Pharmacol. 42: 2011-2018.
50. Meldolesi, J., G. Gatti, A. Ambrosini, T. Pozzan & E. W. Westhead. 1988. Second-messenger control of catecholamine release from PC12 cells. Role of muscarinic receptors and nerve-growth-factor-induced cell differentiation. Biochem. J. 255: 761-768.
51. 2-adrenergic agonists on carbachol-stimulated catecholamine synthesis in cultured bovine adrenal medullary cells. Biochem. Pharmacol. 36: 3823-3828.
52. 2 receptors. Curr. Eye Res. 15: 943-950.
53. Musgrave, I. F., D. Krautwurst & G. Schultz. 1996. Imidazoline binding sites and signal transduction pathways. Clin. Exp. Pharmacol. Physiol. 23: 990-994.
54. 1-imidazoline binding sites. Neurochem. Int. 30: 17-23.
55. Felsen, D., P. Ernsberger, P. M. Sutaria, R. J. Nejat, P. Nguyen, M. May, D. S. Breslin, D. N. Marion & E. D. Vaughan, Jr. 1994. Identification, localization and functional analysis of imidazoline and α-adrenergic receptors in canine prostate. J. Pharmacol. Exp. Ther. 268: 1063-1071.
56. Roivainen, R., T. McMahon & R. O. Messing. 1993. Protein kinase C isozymes that mediate enhancement of neurite outgrowth by ethanol and phorbol esters in PC12 cells. Brain Res. 624: 85-93.
57. 1-Imidazoline binding sites in PC 12 cells are up-regulated by nerve growth factor (NGF). Soc. Neurosci. Abstr. 18: 622.
58. Chan, C. K. S., F. Sannajust & G. A. Head. 1996. Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits. J. Pharmacol. Exp. Ther. 276: 411-420.
59. Müller-Decker, K. 1989. Interruption of TPA-induced signals by an antiviral and antitumoral xanthate compound: Inhibition of a phospholipase C-type reaction. Biochem. Biophys. Res. Commun. 162: 198-205.
60. 1-imidazoline receptors in PC12 pheochromocytoma cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 358: R670.
61. Carroll, J. M., M. J. Evinger, H. M. Goodman & T. H. Joh. 1991. Differential and coordinate regulation of TH and PNMT mRNAs in chromaffin cell cultures by second messenger system activation and steroid treatment. J. Mol. Neurosci. 3: 75-83.
62. Bazan, N. G., M. G. Packard, L. Teather & G. Allan. 1997. Bioactive lipids in excitatory neurotransmission and neuronal plasticity. Neurochem. Int. 30: 225-231.
63. Armah, B. I., E. Hofferber & W. Stenzel. 1988. General pharmacology of the novel centrally acting antihypertensive agent moxonidine. Arzneim.-Forsch. 38: 1426-1434.
64. Trachte, G. J., P. J. Hook, J. R. Kemp, E. P. Acosta & R. J. Ziegler. 1988. Thromboxane synthesis and actions in isolated adrenergic nerve (pheochromocytoma-12) cells. J. Pharmacol. Exp. Ther. 247: 43-46.
65. Darkwa, F. K. & D. D. Smyth. 1995. Inhibition of the natriuretic action of the imidazoline receptor agonist monoxidine by indometacin in the rat. Pharmacology 51: 347-355.
66. Ercan, Z. S., N. M. Bor & R. K. Turker. 1979. The role of endogenous prostaglandins in the renal vascular response to clonidine. Arch. Int. Pharmacodyn. Ther. 239: 319-325.
67. Siren, A.-L. & H. Karppanen. 1980. Influence of analgesic antipyretics on the central cardiovascular effects of clonidine in rats. Prostaglandins 20: 285-296.
68. 1-imidazoline receptors. J. Auton. Nerv. Syst. (In press).
69. 1-imidazoline receptors. J. Auton. Nerv. Syst. 65: 144.
70. 2-adrenoceptor antagonist in human frontal cortex membranes. Neurochem. Int. 18: 137-140.
71. 2 and of adenylate cyclase in transfected Chinese hamster ovary cells is mediated by different mechanisms. Mol. Pharmacol. 39: 239-245.
72. 2+ channels through a pertussis toxin-sensitive guanine nucleotide-binding protein. J. Pharmacol. Exp. Ther. 266: 1113-1124.
73. + exchanger. Am. J. Physiol. Renal, Fluid Electrolyte Physiol. 258: F636-F642.
74. Schachter, J. B., D. S. Lester & D. L. Alkon. 1996. Synergistic activation of protein kinase C by arachidonic acid and diacylglycerols in vitro: Generation of a stable membrane-bound, cofactor-independent state of protein kinase C activity. Biochim. Biophys. Acta 1291: 167-176.
75. 2-adrenergic receptors by protein kinase C phosphorylation. FASEB J. 12: A743.
76. Regunathan, S. & D. J. Reis. 1994. Effects of moxonidine, an imidazoline antihypertensive agent, on second messenger systems in rat brain. Eur. J. Pharmacol. Mol. Pharmacol. 269: 273-276.
77. Regunathan, S., S. Bramwell & D. J. Reis. 1995. Effects of rilmenidine on signal transduction mechanisms associated with alpha 2-adrenergic and imidazoline receptors in brain. Ann. N.Y. Acad. Sci. 763: 290-294.
78. Ogidigben, M., T.-C. Chu & D. E. Potter. 1994. Ocular actions of moxonidine: A possible role for imidazoline receptors. J. Pharmacol. Exp. Ther. 269: 897-904.
79. Shepherd, R. M., M. N. Hashmi, C. Kane, P. E. Squires & M. J. Dunne. 1996. Elevation of cytosolic calcium by imidazolines in mouse islets of Langerhans: Implications for stimulus-response coupling of insulin release. Br. J. Pharmacol. 119: 911-916.
80. ATP channels and interaction with the exocytotic machinery. Diabetes 45: 1610-1618.
81. 1-imidazoline receptor binding properties of 2-(4′-isothiocyantobenzyl)-imidazoline analogs in vascular and brain tissues. Ann. N.Y. Acad. Sci. 763: 283-286.
82. Dyck, L. E. 1989. Inhibition of polyphosphoinositide turnover in rat cerebral cortex by clonidine. Life Sci. 45: 993-999.
83. Taube, C., K. Pönicke, I. Heinroth, H.-U. Block, P. Mentz & W. Förster. 1976. The influence of antihypertensive drugs on the synthesis and metabolism of prostaglandins. Acta Biol. Med. Germ. 35: 1227-1228.
84. + exchangers in cultured cells. Biochem. J. 280: 317-322.
85. + transport and intracellular pH in renal proximal tubule cells. Biochim. Biophys. Acta Bio-Membr. 1024: 173-178.
86. 1-imidazoline receptors in PC12 cells. FASEB J. 9: A114.